The Catalyst Issue 15 | November 2012 | Page 10

Deeper expertise and a broader reach are transforming more patients’ lives Cancer Care J anelle Comiskey, of Leander, Texas, had a feeling something was wrong. She felt a thickening in her right breast, although it didn’t feel like a lump. She had had a clean result on a mammogram a few months earlier, in August 2010, and was disturbed about this turn of events. To be on the safe side, her primary care physician referred her to Scott & White Healthcare - Round Rock Chief Medical Officer Rob W. Watson, MD, assistant professor of surgery, Texas A&M Health Science Center College of Medicine, who ordered an ultrasound and an additional mammography exam. Nothing suspicious showed up, but Dr. Watson and his patient decided that the best course of action was to remove the mysterious mass. In a small percentage of cases, breast cancer is difficult to detect. After her surgery, Mrs. Comiskey, age 45, was diagnosed with triple negative breast cancer, an aggressive form of the disease. It gets its name because triple negative breast cancer is unresponsive to targeted therapies used to block estrogen, progesterone, and human epidermal growth factor receptors. Conventional treatments, such as chemotherapy and radiation, would find some success in treating this rare patient, but Mrs. Comiskey was in for the fight of her life. She immediately began chemotherapy followed by bilateral mastectomies. Expanded specialty care Learning you have cancer is a devastating experience. The good news is that diagnostic improvements and promising therapies continue to emerge. That’s why focusing attention on new treatments, screening exams, and medications that extend and improve the quality of life and increase survival Scott & White is one of the first providers in Central Texas to be recognized by the American College of Surgeons’ National Accreditation Program for Breast Centers. 10 The Catalyst November 12 | sw.org rates is paramount. Psychological, emotional, and spiritual support is critically important, too. Scott & White is broadening its reach, by giving patients more access to high-quality cancer care, with a multidisciplinary and personalized approach toward treatment. For Scott & White patients, that expertise originates from the Glenda Tanner Vasicek Cancer Treatment Center on the Scott & White Memorial Hospital campus in Temple, Texas. Specialized oncology care is now being enhanced and introduced at the healthcare system’s regional locations. New Scott & White Healthcare cancer centers are in development in Waco at Hillcrest Baptist Medical Center Scott & White Healthcare, and at Scott & White hospital locations in Round Rock and College Station (see pages 6–7). The entire system of regional cancer centers, combined with the tertiary care at the Vasicek Center will constitute the Scott & White Cancer Institute. Scott & White’s legacy is built on a cohesive model of clinical care, and today this is helping more patients like Mrs. Comiskey access unprecedented expertise in their own communities.